Arrowhead Pharmaceuticals Inc (ARWR)vsRevolution Medicines Inc (RVMD)
ARWR
Arrowhead Pharmaceuticals Inc
$60.21
+2.00%
HEALTHCARE · Cap: $7.90B
RVMD
Revolution Medicines Inc
$190.27
+0.82%
HEALTHCARE · Cap: $38.14B
Smart Verdict
WallStSmart Research — data-driven comparison
Arrowhead Pharmaceuticals Inc generates 90128% more annual revenue ($669.50M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -47.8%. ARWR earns a higher WallStSmart Score of 32/100 (F).
ARWR
Avoid32
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 171.0% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Trading at 18.2x book value
Elevated debt levels
ROE of -68.7% — below average capital efficiency
Negative free cash flow — burning cash
Trading at 15.6x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : ARWR
The strongest argument for ARWR centers on Revenue Growth. Revenue growth of 171.0% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : ARWR
The primary concerns for ARWR are Price/Book, Debt/Equity, Return on Equity. Debt-to-equity of 1.86 is elevated, increasing financial risk.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
ARWR profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.40 — expect wider price swings.
ARWR is growing revenue faster at 171.0% — sustainability is the question.
ARWR generates stronger free cash flow (-181M), providing more financial flexibility.
Bottom Line
ARWR scores higher overall (32/100 vs 24/100) and 171.0% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Arrowhead Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Arrowhead Pharmaceuticals, Inc. develops drugs for the treatment of intractable diseases in the United States. The company is headquartered in Pasadena, California.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?